These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 8452572

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. (Methoxyalkyl)thiazoles: a new series of potent, selective, and orally active 5-lipoxygenase inhibitors displaying high enantioselectivity.
    Bird, Bruneau P, Crawley GC, Edwards MP, Foster SJ, Girodeau JM, Kingston JF, McMillan RM.
    J Med Chem; 1991 Jul; 34(7):2176-86. PubMed ID: 1648621
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hydroxamic acids and hydroxyureas as novel, selective 5-lipoxygenase inhibitors for possible use in asthma.
    Payne AN, Jackson WP, Salmon JA, Nicholls A, Yeadon M, Garland LG.
    Agents Actions Suppl; 1991 Jul; 34():189-99. PubMed ID: 1793063
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Methoxytetrahydropyrans. A new series of selective and orally potent 5-lipoxygenase inhibitors.
    Crawley GC, Dowell RI, Edwards PN, Foster SJ, McMillan RM, Walker ER, Waterson D, Bird TG, Bruneau P, Giroaeau JM.
    J Med Chem; 1992 Jul 10; 35(14):2600-9. PubMed ID: 1321908
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Substituted thiopyrano[2,3,4-c,d]indoles as potent, selective, and orally active inhibitors of 5-lipoxygenase. Synthesis and biological evaluation of L-691,816.
    Hutchinson JH, Riendeau D, Brideau C, Chan C, Delorme D, Denis D, Falgueyret JP, Fortin R, Guay J, Hamel P.
    J Med Chem; 1993 Sep 17; 36(19):2771-87. PubMed ID: 8410991
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. EPR investigation of the active site of recombinant human 5-lipoxygenase: inhibition by selenide.
    Hammarberg T, Kuprin S, Rådmark O, Holmgren A.
    Biochemistry; 2001 May 29; 40(21):6371-8. PubMed ID: 11371199
    [Abstract] [Full Text] [Related]

  • 18. Failure of the inhibition of rat gastric mucosal 5-lipoxygenase by novel acetohydroxamic acids to prevent ethanol-induced damage.
    Boughton-Smith NK, Whittle BJ.
    Br J Pharmacol; 1988 Sep 29; 95(1):155-62. PubMed ID: 3146394
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of human leukocyte 5-lipoxygenase by a 4-hydroxybenzofuran, L-656,224. Evidence for enzyme reduction and inhibitor degradation.
    Rouzer CA, Riendeau D, Falgueyret JP, Lau CK, Gresser MJ.
    Biochem Pharmacol; 1991 May 01; 41(9):1365-73. PubMed ID: 2018568
    [Abstract] [Full Text] [Related]

  • 20. Guinea pig whole blood 5-lipoxygenase assay: utility in the assessment of potential 5-lipoxygenase inhibitors.
    Spaethe SM, Snyder DW, Pechous PA, Clarke T, VanAlstyne EL.
    Biochem Pharmacol; 1992 Jan 22; 43(2):377-82. PubMed ID: 1310855
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.